Kari Alitalo

Academy Professor at Academy of Finland

Kari Alitalo

Kari Alitalo

Academy Professor at Academy of Finland

Overview
RelSci Relationships

300

Number of Boards

3

Birthday

05/21/1952

Age

68

Number of Awards

3

Relationships
RelSci Relationships are individuals Kari Alitalo likely has professional access to. A relationship does not necessarily indicate a personal connection.

Regents Professor & Vice Chairman, Systems Biology & Translational Medicine at Texas A&M Health Science Center - College of Medicine

Relationship likelihood: Strong

Chief of Consultative Cardiology at Stanford University - School of Medicine

Relationship likelihood: Strong

Physician at New York Presbyterian Hospital

Relationship likelihood: Strong

Faculty Member at UCSF School of Medicine

Relationship likelihood: Strong

Consultant Skin Physician at The Royal Marsden Hospital

Relationship likelihood: Strong

John Rodman Paul Professor Emerita of Epidemiology & Public Health, Department of Epidemiology of Microbial Diseases at Yale University - Yale School of Public Health

Relationship likelihood: Strong

William B. Ogden Professor of Molecular Engineering & Deputy Dean for Faculty Affairs at University of Chicago - Pritzker School of Molecular Engineering

Relationship likelihood: Strong

Professor of Human Genetics at De Duve Institute

Relationship likelihood: Strong

Chief Scientific Officer at Herantis Pharma Oyj

Relationship likelihood: Strong

Professor-Emeritus at École Polytechnique Fédérale de Lausanne

Relationship likelihood: Strong

Paths to Kari Alitalo
Potential Connections via
Relationship Science
You
Kari Alitalo
Academy Professor at Academy of Finland
Education
M.Sc.D.
Class of 1980

The University of Helsinki is a university located in Helsinki, Finland since 1829, but was founded in the city of Turku (in Swedish Åbo) in 1640 as The Royal Academy of Turku, at that time part of the Swedish Empire. It is the oldest and largest university in Finland with the widest range of disciplines available. Around 36,500 students are currently enrolled in the degree programs of the university spread across 11 faculties and 11 research institutes. As of August 1, 2005, the University complies with the standards of the Europe-wide Bologna Process and offers Bachelor, Master, Licenciate, and Doctoral degrees. Admission to degree programmes is usually determined by entrance examinations, in the case of bachelor degrees, and by prior degree results, in the case of master and postgraduate degrees. Entrance is particularly selective (circa 15% of the yearly applicants are admitted). It has been ranked a top 100 university in the world according to the 2012 QS, Times Higher Education and the Academic Rankings of World Universities. The university is bilingual, with teaching provided both in Finnish and Swedish. Teaching in English is extensive throughout the university at Master, Licentiate, and Doctoral levels, making it a de facto third language of instruction. Remaining true to its traditionally strong Humboldtian ethos, the University of Helsinki places heavy emphasis on high-quality teaching and research of a top international standard.[6] It is a member of various prominent international university networks, such as Europaeum, UNICA, the Utrecht Network, and is a founding member of the League of European Research Universities.

Memberships
Member
Current

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

Member
Current

ASCB IS AN INCLUSIVE, INTERNATIONAL COMMUNITY OF BIOLOGISTS STUDYING THE CELL, THE FUNDAMENTAL UNIT OF LIFE. WE ARE DEDICATED TO ADVANCING SCIENTIFIC DISCOVERY, ADVOCATING SOUND RESEARCH POLICIES, IMPROVING EDUCATION, PROMOTING PROFESSIONAL DEVELOPMENT, AND INCREASING DIVERSITY AND INCLUSIVITY IN THE SCIENTIFIC WORKFORCE.

Career History
Visiting Scientist, Department of Microbiology & Immunology
1982 - 1983

The University of California, San Francisco (UCSF), is a center of health sciences research, patient care, and education; located in San Francisco, California. UCSF is widely regarded as one of the world's leading universities in health sciences. Though one of the 10 campuses of the University of California, it is unique for being the only University of California campus dedicated solely to graduate education, and in health and biomedical sciences. Some of UCSF's treatment centers include kidney transplants and liver transplantation, radiology, neurosurgery, neurology, oncology, ophthalmology, gene therapy, women's health, fetal surgery, pediatrics, and internal medicine.

Academy Professor
Current
Professor, Medical Biochemistry
1986 - 1987
Boards & Committees
Member, Scientific Advisory Board
Current

Herantis Pharma Oyj engages in the research and development of biopharmaceutical products. It offers medicinal products such as Cis-UCA eye drops for dry eye, CDNF for Parkinson's disease, Lymfactin for secondary lymphedema, Cis-UCA emulsion cream for atopic dermatitis, and CDNF for amyotrophic lateral sclerosis (ALS). The company was founded by Eero Hemminki Castren, Henri Juhani Huttunen, Heikki Rauvala, and Mart Saarma in 2008 and is headquartered in Espoo, Finland.

Member, Scientific & Medical Advisory Council
1999 - Current

Since 1998, the Lymphatic Research Foundation (LRF) has been looking for answers for the millions of people who suffer from lymphedema and lymphatic disease. LRF fosters and supports research that can deepen the medical community's understanding of the lymphatic system, which is vital to the health of every individual. Unraveling the mysteries of the lymph­atic system is critical to understanding many other disease processes. As an integral part of the immune system, the lymphatic system is the body's surveillance against cancer, and it can provide pathways for cancer to metastasize. It plays a role in inflammatory and auto-immune disorders such as arthritis and systemic lupus, and is key to understanding the spread of AIDS and many infections. LRF fosters and supports research to discover the links between lymph­atic function, diseases, and levels of wellness. The Lymphatic Research Foundation is a 501(c)(3) not-for profit organization whose mission is to ad­vance re­search of the lymphatic system and to find the cause of and cure for lymphatic dis­eases, lymphedema, and related disorders. LRF's immediate goals are to increase public and private funding for lymphatic research and to increase public awareness.

Member, Fund Committee
1994 - 1997
Awards & Honors
2006
Louis-Jeantet Prize for Medicine
2005
Eric K Fernström Foundation - Nordic Prize
2003
Leopold Griffuel Prize
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kari Alitalo. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kari Alitalo's profile does not indicate a business or promotional relationship of any kind between RelSci and Kari Alitalo.